Effects of treatment modalities for Graves' hyperthyroidism on Graves' orbitopathy: a 2015 Italian Society of Endocrinology Consensus Statement

被引：38
作者：
Bartalena, L. [1 ]
Macchia, P. E. [2 ]
Marcocci, C. [3 ]
Salvi, M. [4 ,5 ]
Vermiglio, F. [6 ]
机构：
[1] Univ Insubria, Endocrine Unit, Dept Clin & Expt Med, Osped Circolo, Viale Borri 57, I-21100 Varese, Italy
[2] Univ Naples Federico II, Dept Clin Med & Surg, Naples, Italy
[3] Univ Pisa, Dept Clin & Expt Med, Pisa, Italy
[4] Fdn Ca Granda IRCCS, Dept Clin Sci & Community Hlth, Graves Orbitopathy Ctr, Milan, Italy
[5] Univ Milan, Milan, Italy
[6] Univ Messina, Dept Clin & Expt Med, Messina, Italy
来源：
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION | 2015年 / 38卷 / 04期
关键词：
Graves' disease; Graves' orbitopathy; Antithyroid drugs; Thionamides; Radioiodine; Thyroidectomy; Glucocorticoids; RADIOACTIVE IODINE THERAPY; NEAR-TOTAL THYROIDECTOMY; RADIOIODINE THERAPY; STEROID PROPHYLAXIS; OPTIC NEUROPATHY; NATURAL-HISTORY; CLINICAL-TRIAL; DRUG-THERAPY; OPHTHALMOPATHY; DISEASE;
D O I：
10.1007/s40618-015-0257-z
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：481 / 487
页数：7
相关论文
共 59 条
[1]   A systematic review of drug therapy for Graves' hyperthyroidism [J].
Abraham, P ;
Avenell, A ;
Park, CM ;
Watson, WA ;
Bevan, JS .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2005, 153 (04) :489-498
[2]   Radioiodine therapy (RAI) for Graves' disease (GD) and the effect on ophthalmopathy: a systematic review [J].
Acharya, Shamasunder H. ;
Avenell, Alison ;
Philip, Sam ;
Burr, Jennifer ;
Bevan, John S. ;
Abraham, Prakash .
CLINICAL ENDOCRINOLOGY, 2008, 69 (06) :943-950
[3]   Management of Graves' ophthalmopathy: Reality and perspectives [J].
Bartalena, L ;
Pinchera, A ;
Marcocci, C .
ENDOCRINE REVIEWS, 2000, 21 (02) :168-199
[4]   A 2013 European survey of clinical practice patterns in the management of Graves' disease [J].
Bartalena, L. ;
Burch, H. B. ;
Burman, K. D. ;
Kahaly, G. J. .
CLINICAL ENDOCRINOLOGY, 2016, 84 (01) :115-120
[5]   Efficacy and Safety of Three Different Cumulative Doses of Intravenous Methylprednisolone for Moderate to Severe and Active Graves' Orbitopathy [J].
Bartalena, L. ;
Krassas, G. E. ;
Wiersinga, W. ;
Marcocci, C. ;
Salvi, M. ;
Daumerie, C. ;
Bournaud, C. ;
Stahl, M. ;
Sassi, L. ;
Veronesi, G. ;
Azzolini, C. ;
Boboridis, K. G. ;
Mourits, M. P. ;
Soeters, M. R. ;
Baldeschi, L. ;
Nardi, M. ;
Curro, N. ;
Boschi, A. ;
Bernard, M. ;
von Arx, G. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (12) :4454-4463
[6]   Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy [J].
Bartalena, L ;
Marcocci, C ;
Bogazzi, F ;
Manetti, L ;
Tanda, ML ;
Dell'Unto, E ;
Bruno-Bossio, G ;
Nardi, M ;
Bartolomei, MP ;
Lepri, A ;
Rossi, G ;
Martino, E ;
Pinchera, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (02) :73-78
[7]   USE OF CORTICOSTEROIDS TO PREVENT PROGRESSION OF GRAVES OPHTHALMOPATHY AFTER RADIOIODINE THERAPY FOR HYPERTHYROIDISM [J].
BARTALENA, L ;
MARCOCCI, C ;
BOGAZZI, F ;
PANICUCCI, M ;
LEPRI, A ;
PINCHERA, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (20) :1349-1352
[8]   Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO [J].
Bartalena, Luigi ;
Baldeschi, Lelio ;
Dickinson, Alison ;
Eckstein, Anja ;
Kendall-Taylor, Pat ;
Marcocci, Claudio ;
Mourits, Maarten ;
Perros, Petros ;
Boboridis, Kostas ;
Boschi, Antonella ;
Curro, Nicola ;
Daumerie, Chantal ;
Kahaly, George J. ;
Krassas, Gerasimos E. ;
Lane, Carol M. ;
Lazarus, John H. ;
Marino, Michele ;
Nardi, Marco ;
Neoh, Christopher ;
Orgiazzi, Jacques ;
Pearce, Simon ;
Pinchera, Aldo ;
Pitz, Susanne ;
Salvi, Mario ;
Sivelli, Paolo ;
Stahl, Matthias ;
von Arx, Georg ;
Wiersinga, Wilmar M. .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2008, 158 (03) :273-285
[9]   Steroid Prophylaxis After Radioiodine Treatment for Graves' Hyperthyroidism: Selective or Universal? [J].
Bartalena, Luigi .
THYROID, 2014, 24 (10) :1441-1442
[10]   Extrathyroidal manifestations of Graves' disease: a 2014 update [J].
Bartalena, Luigi ;
Fatourechi, Vahab .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2014, 37 (08) :691-700
123456